JHA-14962-91726
5 vaccinations
2 coded responses
28 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 265 / WV
- Registered
- 2020-12-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
6C5-20818-28917
Child or adolescent in my care · Male · 2021-11-07
Timeline
-
2020-12-15
Registered in v-safe
-
2020-12-15
Dose 1 — Pfizer-BioNTech
- 2020-12-15
- 2020-12-16
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-29
- 2021-01-05
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-06
- 2021-01-07
- 2021-01-09
- 2021-01-10
- 2021-01-15
- 2021-01-20
- 2021-01-27
-
2021-02-03
Survey response — day 28, dose 2MedDRA: Menstrual disorder — Feeling: GoodFree text: My menstrual cycle has been off since my second dose. I had mid cycle bleeding which is abnormal for me and then my period was late then longer than normal with a lighter flow.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-10
- 2021-02-17
- 2021-04-07
- 2021-07-07
-
2021-08-24
Dose 3 — Moderna
- 2022-01-06
-
2022-03-02
Dose 4 — Moderna
- 2022-04-14
- 2022-06-01
-
2022-08-31
Survey response — 6 months, dose 4MedDRA: COVID-19, Impaired work ability, Malaise — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with COVID-19 eight days ago and took time off work to recover from symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-31
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-01
-
2022-09-01
Call successfulParticipant prefers to complete VAERS report online
-
2022-11-15
Dose 5 — Moderna
- 2023-03-02
- 2023-05-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-15 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-08-24 | Moderna | No |
| 4 | 2022-03-02 | Moderna | No |
| 5 | 2022-11-15 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 3 — day 28, dose 2
Symptoms: My menstrual cycle has been off since my second dose. I had mid cycle bleeding which is abnormal for me and then my period was late then longer than normal with a lighter flow.
Release 12 — 6 months, dose 4
Symptoms: Diagnosed with COVID-19 eight days ago and took time off work to recover from symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release